TELA BIO INC's ticker is TELA and the CUSIP is 872381108. A total of 37 filers reported holding TELA BIO INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $570,400 | -69.1% | 71,300 | -60.9% | 0.00% | -75.0% |
Q2 2023 | $1,846,699 | -19.3% | 182,300 | -15.2% | 0.02% | -27.3% |
Q1 2023 | $2,288,121 | +2.4% | 215,049 | +10.7% | 0.02% | +15.8% |
Q4 2022 | $2,233,565 | +65.0% | 194,223 | +22.3% | 0.02% | +72.7% |
Q3 2022 | $1,354,000 | +37.6% | 158,823 | +13.1% | 0.01% | +10.0% |
Q2 2022 | $984,000 | -41.9% | 140,372 | -3.7% | 0.01% | -33.3% |
Q1 2022 | $1,694,000 | -8.2% | 145,736 | +1.1% | 0.02% | -11.8% |
Q4 2021 | $1,845,000 | -6.4% | 144,136 | -0.2% | 0.02% | -15.0% |
Q3 2021 | $1,972,000 | -10.6% | 144,353 | +5.4% | 0.02% | -13.0% |
Q2 2021 | $2,206,000 | +23.9% | 136,953 | +14.6% | 0.02% | +4.5% |
Q1 2021 | $1,780,000 | -8.9% | 119,486 | -8.0% | 0.02% | -15.4% |
Q4 2020 | $1,953,000 | -12.3% | 129,849 | -3.6% | 0.03% | -38.1% |
Q3 2020 | $2,228,000 | -44.8% | 134,749 | -56.8% | 0.04% | -22.2% |
Q2 2020 | $4,038,000 | +1471.2% | 311,676 | +850.0% | 0.05% | +237.5% |
Q1 2020 | $257,000 | -81.9% | 32,808 | -70.1% | 0.02% | -54.3% |
Q4 2019 | $1,419,000 | – | 109,600 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 4,110,709 | $32,885,672 | 28.99% |
Velan Capital Investment Management LP | 746,087 | $5,968,696 | 4.81% |
AIGH Capital Management LLC | 1,252,945 | $10,023,560 | 4.74% |
Opaleye Management Inc. | 750,000 | $6,000,000 | 1.95% |
First Light Asset Management, LLC | 2,480,264 | $19,842,112 | 1.88% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 159,775 | $1,278,200 | 1.80% |
PERKINS CAPITAL MANAGEMENT INC | 190,500 | $1,524 | 1.51% |
Worth Venture Partners, LLC | 314,220 | $2,513,760 | 1.49% |
Stonepine Capital Management, LLC | 491,919 | $3,935,352 | 1.31% |
SILVERARC CAPITAL MANAGEMENT, LLC | 490,471 | $3,923,768 | 1.19% |